Alan K. Smith
Directeur/Membre du Conseil chez CHATA Biosystems, Inc.
Profil
Alan K.
Smith is currently a Director at CHATA Biosystems, Inc. and a Director at Armis Biopharma, Inc. He previously held positions such as President & Chief Executive Officer at Cognate BioServices, Inc., Vice President-Research at Vericel Corp., and COO, SVP-Research & Development at Osiris Therapeutics, Inc. He was also President & Chief Operating Officer at Theradigm, Inc. and Executive Vice President-Technical Operations at Bellicum Pharmaceuticals, Inc. Additionally, he was Vice President-Cellular Therapeutics, R&D at LifeNet Health, Inc. and Chief Technology Officer at Akouos, Inc. Dr. Smith received his undergraduate degree from Southern Utah University and his doctorate from Utah State University in 1983.
Postes actifs de Alan K. Smith
| Sociétés | Poste | Début |
|---|---|---|
CHATA Biosystems, Inc.
 CHATA Biosystems, Inc. Wholesale DistributorsDistribution Services CHATA Biosystems, Inc. manufactures pre-packaged chemical solutions. It offers its products to the pharmaceutical, biotechnology, agricultural, beverages, and electronics industries. The company was founded in 1998 and is headquartered in Loveland, CO. | Directeur/Membre du Conseil | - |
Armis Biopharma, Inc.
 Armis Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Armis Biopharma, Inc. is a privately held biopharmaceutical company based in Fort Collins, CO. The company is focused on developing and commercializing products that reduce the risk of infectious disease, decontaminate chemical warfare agents, and provide differentiated medical devices. The company was founded by Edwin D. Neas and has been led by CEO Ted E. Ziemann since 2000. | Directeur/Membre du Conseil | 01/01/1998 |
Anciens postes connus de Alan K. Smith
| Sociétés | Poste | Fin |
|---|---|---|
| AKOUOS | Directeur Technique/Scientifique/R&D | 01/11/2021 |
| BELLICUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 24/06/2020 |
LifeNet Health, Inc.
 LifeNet Health, Inc. Medical/Nursing ServicesHealth Services LifeNet Health, Inc. operates as a full-service organ donation agency and tissue banking system. It offers cardiac, vascular, sports medicine, general orthopedics and trauma, craniomaxillofacial, spine, dental, plastic and reconstructive surgical services. The company was founded in 1982 and is headquartered in Virginia Beach, VA. | Corporate Officer/Principal | 01/10/2015 |
Theradigm, Inc.
 Theradigm, Inc. Medical/Nursing ServicesHealth Services Theradigm develops stem-cell-based therapies to treat diseases of the central nervous system. Building upon promising pre-clinical data, Theradigm is initially pursuing treatments for stroke and spinal cord injury. Other treatments under development will address traumatic brain injury. Theradigm's stem cells are used to provide trophic support, and potentially to rescue or replace injured tissue in the central nervous system. | President | 30/07/2010 |
| OSIRIS THERAPEUTICS, INC. | Directeur des opérations | 01/01/2002 |
Formation de Alan K. Smith
| Utah State University | Doctorate Degree |
| Southern Utah University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Entreprise privées | 9 |
|---|---|
CHATA Biosystems, Inc.
CHATA Biosystems, Inc. Wholesale DistributorsDistribution Services CHATA Biosystems, Inc. manufactures pre-packaged chemical solutions. It offers its products to the pharmaceutical, biotechnology, agricultural, beverages, and electronics industries. The company was founded in 1998 and is headquartered in Loveland, CO. | Distribution Services |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Theradigm, Inc.
Theradigm, Inc. Medical/Nursing ServicesHealth Services Theradigm develops stem-cell-based therapies to treat diseases of the central nervous system. Building upon promising pre-clinical data, Theradigm is initially pursuing treatments for stroke and spinal cord injury. Other treatments under development will address traumatic brain injury. Theradigm's stem cells are used to provide trophic support, and potentially to rescue or replace injured tissue in the central nervous system. | Health Services |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
LifeNet Health, Inc.
LifeNet Health, Inc. Medical/Nursing ServicesHealth Services LifeNet Health, Inc. operates as a full-service organ donation agency and tissue banking system. It offers cardiac, vascular, sports medicine, general orthopedics and trauma, craniomaxillofacial, spine, dental, plastic and reconstructive surgical services. The company was founded in 1982 and is headquartered in Virginia Beach, VA. | Health Services |
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Armis Biopharma, Inc.
Armis Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Armis Biopharma, Inc. is a privately held biopharmaceutical company based in Fort Collins, CO. The company is focused on developing and commercializing products that reduce the risk of infectious disease, decontaminate chemical warfare agents, and provide differentiated medical devices. The company was founded by Edwin D. Neas and has been led by CEO Ted E. Ziemann since 2000. | Health Technology |
